Asasantin®

DRUG2 trials

Sponsors

Boehringer Ingelheim

Conditions

Healthy

Phase 1

Effects of Acetylsalicylic Acid Compared With the Combination of Acetylsalicylic Acid + Modified-release Dipyridamole on Serum Thromboxane B2 Formation and Platelet Aggregation in Healthy Volunteers

CompletedNCT02268773

Boehringer IngelheimHealthy

Start: 2000-01-31Updated: 2014-10-20

Pharmacokinetics and Safety of Asasantin Extended Release (RAD-SP) Capsules in Japanese Healthy Male Volunteers

CompletedNCT02273479

Boehringer IngelheimHealthy

Start: 1999-07-31Updated: 2014-10-24